MEDYTOX
Medytox Investments is a medical aesthetic company that offers product botulinum, toxin product, hyaluronic acid filler medical device. It also offers services such as public information, financial information, stock price information.
MEDYTOX
Social Links:
Industry:
Manufacturing Medical
Founded:
2000-05-02
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Tag Manager Google Universal Analytics Apache Global Site Tag Euro
Current Employees Featured
Founder
Stock Details
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2018-06-18 | Lifesprout | Medytox investment in Seed Round - Lifesprout | 6.5 M USD |
More informations about "Medytox"
About Medytox
Based on integrity and open communication, Medytox is building excellent capacity and system to meet the global standard with commitment and courage. Furthermore, we are endeavoring to โฆSee details»
Medytox, Inc. Announces the Formation of Luvantas โฆ
IRVINE, Calif., Jan. 3, 2024 /PRNewswire/ -- Medytox, Inc. is pleased to announce the formation of Luvantas, Inc. (www.luvantas.com) as its wholly-owned North American subsidiary.See details»
Global Network - Medytox
Medytox is currently exporting products to approximately 60 countries including Japan and Brazil. In addition, we are striving to penetrate the market in the US and European countries in the โฆSee details»
Medytox, Inc. Announces the Formation of Luvantas Subsidiary โฆ
IRVINE, Calif., Jan. 3, 2024 /PRNewswire/ โ Medytox, Inc. is pleased to announce the formation of Luvantas, Inc. (www.luvantas.com) as its wholly-owned North American subsidiary. To read โฆSee details»
Medytox, Inc. Announces the Formation of Luvantas Subsidiary โฆ
IRVINE, Calif., Jan. 3, 2024 /PRNewswire/ -- Medytox, Inc. is pleased to announce the formation of Luvantas, Inc. (www.luvantas.com) as its wholly-owned North American subsidiary.See details»
Medytox, Inc. Announces the Formation of Luvantas Subsidiary โฆ
Jan 8, 2024ย ยท Luvantas is working with Medytox to seek approval for the upcoming introduction of NivobotulinumtoxinA to the United States and Canada. A Biological License Application was โฆSee details»
Medytox Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Medy-Tox, Inc. is a biopharmaceutical company that specializes in producing and distributing various products such as botulinum toxin, hyaluronic acid filler, medical devices, toxin โฆSee details»
Medytox, Inc. Announces Executive Appointments in Luvantas, Inc
Jan 3, 2024ย ยท Medytox Inc. announced the formation of Luvantas Inc. as its wholly-owned North American subsidiary. In connection with the formation of Luvantas, Thomas A. Albright has โฆSee details»
Medytox Plants US Base in Irvine - Orange County Business Journal
Jan 15, 2024ย ยท South Korean biopharmaceutical firm Medytox Inc., a neurotoxin manufacturer that previously partnered with local drugmaker Allergan, has formed a new domestic subsidiary โฆSee details»
Medytox - Crunchbase Investor Profile & Investments
Medytox is a medical aesthetic company that offers product botulinum, toxin product, hyaluronic acid filler medical device. Medytox may be growing as the establishment of a US base in Irvine โฆSee details»
History - Medytox
Established Medytox Inc. (May 2nd) ๊ธ๋ก๋ฒ ๋ฐ์ด์ค์ ์ฝ ๊ธฐ์ ๋ฉ๋ํก์ค์ ๋๋ค.See details»
Medytox, Inc. Announces the Formation of Luvantas Subsidiary โฆ
Jan 3, 2024ย ยท Medytox, Inc. is pleased to announce the formation of Luvantas, Inc. (www.luvantas.com) as its wholly-owned North American subsidiary.See details»
Allergan Licenses Rights to Medytoxโฆ | American Med Spa โฆ
Jun 25, 2018ย ยท In a deal that could net Medytox up to $362 million, the Seoul-based company will license to Allergan exclusive global rights outside Korea to develop and commercialize โฆSee details»
Medytox | Company Overview & News - Forbes
Medy-Tox, Inc. engages in the manufacture and sale of biopharmaceutical products. Its products include botulinum toxin, hyaluronic acid filler, medical devices, toxin detection kit and...See details»
Medytox | JMP
Korean biopharmaceutical company Medytox is best known for pioneering Neuronox, a botulinum toxin type A (BTX-A)-based product indicated for both aesthetic and medical uses as a โฆSee details»
Medytox - Funding, Financials, Valuation & Investors - Crunchbase
Medytox is a medical aesthetic company that offers product botulinum, toxin product, hyaluronic acid filler medical device.See details»
MT-122 - Drug Targets, Indications, Patents - Synapse
Understand key drug designations in just a few clicks with Synapse. MT-122, Initially developed by Medytox Inc., Now, its global highest R&D status is Preclinical, Therapeutic Areas: Immune โฆSee details»
News - Medytox
Since its establishment in 2000, Medytox has developed and evolved into a global world-class R&D company with the successful launch of its main neurotoxin product.See details»
Botulinum toxin A - AbbVie/Medytox - AdisInsight - Springer
Jul 25, 2024ย ยท If your organization has a subscription, there are several access options, even while working remotely: Working within your organizationโs network Login with โฆSee details»
Medy-Tox, Inc. ESG Risk Rating - Sustainalytics
Medy-Tox Inc. is a Korea-based company engaged in the development, manufacture, and marketing of biopharmaceuticals. The company's main product is type-A botulium toxin โฆSee details»